Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Regina Juanbeltz"'
Autor:
Natividad Viguria, Ana Navascués, Regina Juanbeltz, Alberto Echeverría, Carmen Ezpeleta, Jesús Castilla
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 6, Pp 1867-1872 (2021)
To date, there is no consensus regarding palivizumab prophylaxis for respiratory syncytial virus infection. The purpose of this study is to assess the effectiveness of palivizumab prophylaxis to prevent respiratory syncytial virus-related infection c
Externí odkaz:
https://doaj.org/article/042f84f167b84e17bda8eb57e7526885
Autor:
Diana Tejada, Regina Juanbeltz, María Rivero, Ramón San Miguel, Ferrán Capdevila, Juan José Beloqui, Maite Sarobe
Publikováno v:
PLoS ONE, Vol 17, Iss 4, p e0267283 (2022)
BackgroundThere is currently much uncertainty regarding the most optimal treatment for COVID-19. This study analyze the change in the clinical condition of patients hospitalized for severe COVID-19 pneumonia and treated with remdesivir in a real-life
Externí odkaz:
https://doaj.org/article/7242babead0a48859e8058e54a99939a
Autor:
María Rivero, Javier Alonso, María Fernanda Ramón, Nancy Gonzales, Ana Pozo, Itxaso Marín, Ana Navascués, Regina Juanbeltz
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Cellulosimicrobium species, formely known as Oerskovia species, are gram-positive bacilli belonging to the order Actinomycetales. They rarely cause human infections. The genus comprises two pathogenic species in humans: C. cellula
Externí odkaz:
https://doaj.org/article/7710858258674cd881cc756bc9671e6b
Autor:
Javier Mar, Oliver Ibarrondo, Iván Martínez-Baz, Regina Juanbeltz, Ramón San-Miguel, Itziar Casado, Arantzazu Arrospide, Jesús Castilla
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 110, Iss 10, Pp 621-628 (2018)
RESUMEN El elevado coste inicial de los antivirales frente a la hepatitis C impulsó el "Plan Estratégico Nacional para el abordaje de la hepatitis C en el Sistema Nacional de Salud". El objetivo de este estudio fue la evaluación económica de los
Externí odkaz:
https://doaj.org/article/c41cab6c29cd4e35b20270dc3f430a04
Autor:
Regina Juanbeltz, Alejandra Pérez-García, Aitziber Aguinaga, Iván Martínez-Baz, Itziar Casado, Cristina Burgui, Silvia Goñi-Esarte, Jesús Repáraz, José Manuel Zozaya, Ramón San Miguel, Carmen Ezpeleta, Jesús Castilla, EIPT-VHC Study Group
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0208554 (2018)
BackgroundThe World Health Organization set targets to eliminate hepatitis C virus (HCV) infection through detection and treatment of all cases by 2030. This study aimed to describe the progress and difficulties in the elimination of HCV infection in
Externí odkaz:
https://doaj.org/article/39783aea6c5e42018370bad57e281eeb
Autor:
Regina Juanbeltz, Iván Martínez-Baz, Ramón San Miguel, Silvia Goñi-Esarte, Juan Manuel Cabasés, Jesús Castilla
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0205277 (2018)
BACKGROUND:Direct-acting antivirals (DAA) have demonstrated high efficacy to achieve sustained virological response (SVR) in chronic hepatitis C patients. We aim to assess the change in health-related quality of life (HRQoL) among patients successful
Externí odkaz:
https://doaj.org/article/378f9fd242bf417ab7d4481be1f9ab08
Autor:
Ana Navascués, Jesús Castilla, Regina Juanbeltz, Natividad Viguria, Carmen Ezpeleta, Alberto Echeverría
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
To date, there is no consensus regarding palivizumab prophylaxis for respiratory syncytial virus infection. The purpose of this study is to assess the effectiveness of palivizumab prophylaxis to prevent respiratory syncytial virus-related infection c
Autor:
José Manuel Zozaya, Juan Isidro Úriz, José Ignacio Herrero, Silvia Goñi Esarte, Regina Juanbeltz, Jesús Castilla
Publikováno v:
Gastroenterología y Hepatología. 43:248-255
There is little information on whether direct-acting antiviral (DAA) treatment can improve liver fibrosis or change glucose and lipid profile in patients with chronic hepatitis C (CHC). We aimed to evaluate the impact of sustained virologic response
Autor:
Diana Tejada, Regina Juanbeltz, María Rivero, Ramón San Miguel, Ferrán Capdevila, Juan José Beloqui, Maite Sarobe
Publikováno v:
PloS one. 17(4)
Background There is currently much uncertainty regarding the most optimal treatment for COVID-19. This study analyze the change in the clinical condition of patients hospitalized for severe COVID-19 pneumonia and treated with remdesivir in a real-lif
Autor:
Cristina Burgui, Jesús Castilla, Ramón San Miguel, Regina Juanbeltz, José Manuel Zozaya, Iván Martínez-Baz, C. Martín
Publikováno v:
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 112(7)
Antecedentes: desde la decada de 1990 se realizan determinaciones de anticuerpos del virus de la hepatitis C (anti-VHC) y los resultados positivos no siempre fueron seguidos de determinacion del ARN-VHC. Algunos de estos pacientes podrian tener una i